{"entity":{"type":"insider","cik":"0001755662","url":"/insider/0001755662","json_url":"/insider/0001755662.json","name":"Clark David Michael","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":11,"first":"2020-02-14","last":"2025-12-23","span_basis":"filed_date"},"name_variants":[{"name":"Clark David Michael","source":"filing","n_filings":11,"first_seen":"2020-02-14","last_seen":"2025-12-23"}],"transactions":[{"id":4230827,"accession":"0001193125-25-330954","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-330954","line_url":"/filing/0001193125-25-330954#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001755662","owner_name":"Clark David Michael","owner_display_name":"Clark David Michael","owner_url":"/insider/0001755662","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25642.0,"shares_display":"25,642","price_per_share":14.1713,"price_display":"14.17","price_state":"stated","total_value":363380.4746,"total_display":"363,380.47","total_whole":"363,380","shares_owned_after":245690.0,"shares_owned_after_display":"245,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-19","filed_date":"2025-12-23","scope":"insider"},{"id":4202571,"accession":"0001193125-25-323147","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-323147","line_url":"/filing/0001193125-25-323147#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001755662","owner_name":"Clark David Michael","owner_display_name":"Clark David Michael","owner_url":"/insider/0001755662","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25643.0,"shares_display":"25,643","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":282073.0,"total_display":"282,073.00","total_whole":"282,073","shares_owned_after":271332.0,"shares_owned_after_display":"271,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-15","filed_date":"2025-12-17","scope":"insider"},{"id":4066604,"accession":"0001193125-25-301019","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-301019","line_url":"/filing/0001193125-25-301019#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001755662","owner_name":"Clark David Michael","owner_display_name":"Clark David Michael","owner_url":"/insider/0001755662","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25643.0,"shares_display":"25,643","price_per_share":10.0976,"price_display":"10.10","price_state":"stated","total_value":258932.7568,"total_display":"258,932.76","total_whole":"258,933","shares_owned_after":296975.0,"shares_owned_after_display":"296,975","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-24","filed_date":"2025-11-26","scope":"insider"},{"id":5108137,"accession":"0001193125-25-266900","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-266900","line_url":"/filing/0001193125-25-266900#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001755662","owner_name":"Clark David Michael","owner_display_name":"Clark David Michael","owner_url":"/insider/0001755662","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25643.0,"shares_display":"25,643","price_per_share":9.5098,"price_display":"9.51","price_state":"stated","total_value":243859.8014,"total_display":"243,859.80","total_whole":"243,860","shares_owned_after":322618.0,"shares_owned_after_display":"322,618","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-04","filed_date":"2025-11-05","scope":"insider"},{"id":2767526,"accession":"0000950170-24-017265","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-017265","line_url":"/filing/0000950170-24-017265#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001755662","owner_name":"Clark David Michael","owner_display_name":"Clark David Michael","owner_url":"/insider/0001755662","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4427.0,"shares_display":"4,427","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":61978.0,"total_display":"61,978.00","total_whole":"61,978","shares_owned_after":253664.0,"shares_owned_after_display":"253,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-15","filed_date":"2024-02-20","scope":"insider"},{"id":2414583,"accession":"0000950170-24-003441","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-003441","line_url":"/filing/0000950170-24-003441#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001755662","owner_name":"Clark David Michael","owner_display_name":"Clark David Michael","owner_url":"/insider/0001755662","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1384.0,"shares_display":"1,384","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":19376.0,"total_display":"19,376.00","total_whole":"19,376","shares_owned_after":266705.0,"shares_owned_after_display":"266,705","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-09","filed_date":"2024-01-09","scope":"insider"},{"id":2414578,"accession":"0000950170-24-003441","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-003441","line_url":"/filing/0000950170-24-003441#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001755662","owner_name":"Clark David Michael","owner_display_name":"Clark David Michael","owner_url":"/insider/0001755662","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8726.0,"shares_display":"8,726","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":122164.0,"total_display":"122,164.00","total_whole":"122,164","shares_owned_after":268089.0,"shares_owned_after_display":"268,089","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-08","filed_date":"2024-01-09","scope":"insider"},{"id":8651047,"accession":"0001209191-23-004082","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-004082","line_url":"/filing/0001209191-23-004082#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001755662","owner_name":"Clark David Michael","owner_display_name":"Clark David Michael","owner_url":"/insider/0001755662","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7382.0,"shares_display":"7,382","price_per_share":13.5,"price_display":"13.50","price_state":"stated","total_value":99657.0,"total_display":"99,657.00","total_whole":"99,657","shares_owned_after":241067.0,"shares_owned_after_display":"241,067","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-18","filed_date":"2023-01-19","scope":"insider"},{"id":8362626,"accession":"0001209191-23-002393","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-002393","line_url":"/filing/0001209191-23-002393#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001755662","owner_name":"Clark David Michael","owner_display_name":"Clark David Michael","owner_url":"/insider/0001755662","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21507.0,"shares_display":"21,507","price_per_share":11.8727,"price_display":"11.87","price_state":"stated","total_value":255346.1589,"total_display":"255,346.16","total_whole":"255,346","shares_owned_after":219566.0,"shares_owned_after_display":"219,566","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-06","filed_date":"2023-01-06","scope":"insider"},{"id":8362553,"accession":"0001209191-23-001404","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-001404","line_url":"/filing/0001209191-23-001404#line-4","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001755662","owner_name":"Clark David Michael","owner_display_name":"Clark David Michael","owner_url":"/insider/0001755662","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8493.0,"shares_display":"8,493","price_per_share":12.0306,"price_display":"12.03","price_state":"stated","total_value":102175.8858,"total_display":"102,175.89","total_whole":"102,176","shares_owned_after":190203.0,"shares_owned_after_display":"190,203","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-04","scope":"insider"},{"id":6853151,"accession":"0001209191-22-045059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-045059","line_url":"/filing/0001209191-22-045059#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001755662","owner_name":"Clark David Michael","owner_display_name":"Clark David Michael","owner_url":"/insider/0001755662","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11322.0,"shares_display":"11,322","price_per_share":12.5,"price_display":"12.50","price_state":"stated","total_value":141525.0,"total_display":"141,525.00","total_whole":"141,525","shares_owned_after":215542.0,"shares_owned_after_display":"215,542","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-05","filed_date":"2022-08-09","scope":"insider"},{"id":3234467,"accession":"0001209191-20-009646","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-009646","line_url":"/filing/0001209191-20-009646#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001755662","owner_name":"Clark David Michael","owner_display_name":"Clark David Michael","owner_url":"/insider/0001755662","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7107.0,"shares_display":"7,107","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":78177.0,"total_display":"78,177.00","total_whole":"78,177","shares_owned_after":146621.0,"shares_owned_after_display":"146,621","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-12","filed_date":"2020-02-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001178879","name":"AMICUS THERAPEUTICS, INC.","url":"/issuer/0001178879","role":"Officer (Chief People Officer)","n_filings":11,"first_seen":"2020-02-14","last_seen":"2025-12-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001755662","retrieved_at":"2026-08-22T13:07:07+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}